Literature DB >> 10898145

Comparative evaluation of a commercial system for identification of Candida lusitaniae.

A Michel-Nguyen1, A Favel, C Chastin, M Selva, P Regli.   

Abstract

The ability of the API Candida system (bioMérieux, France) to identify Candida lusitaniae isolates was evaluated in comparison to the Auxacolor and ID 32C systems using 52 clinical isolates previously identified on the basis of their morphology and their biochemical reactions in the Auxacolor and ID 32C systems. The API Candida system failed to definitively identify most of the strains tested within 24 h. No beta-maltosidase activity was detected in 28 strains, and supplementary tests were required to discriminate Candida lusitaniae, Candida famata and Candida guilliermondii. The API Candida system is not suitable for identification of Candida lusitaniae. In comparison, the Auxacolor system is easy to use and interpret, allowing rapid identification of this species; however, the ID 32C system is required for identification of atypical strains.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10898145     DOI: 10.1007/pl00011231

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  4 in total

1.  Alternative identification test relying upon sexual reproductive abilities of Candida lusitaniae strains isolated from hospitalized patients.

Authors:  F François; T Noël; R Pépin; A Brulfert; C Chastin; A Favel; J Villard
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

2.  Differentiation between atypical isolates of Candida lusitaniae and Candida pulcherrima by determination of mating type.

Authors:  Thierry Noël; Anne Favel; Annie Michel-Nguyen; Abdelhak Goumar; Karim Fallague; Christiane Chastin; Florence Leclerc; Jean Villard
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

3.  Nonsense and missense mutations in FCY2 and FCY1 genes are responsible for flucytosine resistance and flucytosine-fluconazole cross-resistance in clinical isolates of Candida lusitaniae.

Authors:  Martine Florent; Thierry Noël; Gwenaël Ruprich-Robert; Bruno Da Silva; Valérie Fitton-Ouhabi; Christiane Chastin; Nicolas Papon; Florence Chapeland-Leclerc
Journal:  Antimicrob Agents Chemother       Date:  2009-05-04       Impact factor: 5.191

Review 4.  Candida lusitaniae: Biology, Pathogenicity, Virulence Factors, Diagnosis, and Treatment.

Authors:  Manuela Gómez-Gaviria; Héctor M Mora-Montes; Diana F Mendoza-Reyes
Journal:  Infect Drug Resist       Date:  2022-08-31       Impact factor: 4.177

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.